DUENDO

Serial Number 77493965
602

Registration Progress

Application Filed
Jun 9, 2008
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: DUENDO
Previous Owner: Glaxo Group Limited
Classes: 005

Trademark Image

DUENDO

Basic Information

Serial Number
77493965
Filing Date
June 9, 2008
Abandonment Date
March 10, 2009
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Apr 7, 2009
Classes
005

Rights Holder

Glaxo Group Limited

03
Address
Glaxo Wellcome House
Berkeley Avenue
Greenford, Middlesex UB60NN

Ownership History

Glaxo Group Limited

Original Applicant
03
Greenford, Middlesex

Legal Representation

Attorney
Pamela A. May

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

7 events
Date Code Type Description Documents
Apr 7, 2009 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Apr 7, 2009 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Sep 9, 2008 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 9, 2008 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 9, 2008 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 9, 2008 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 12, 2008 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005